Updated Pick,used to help diagnose celiac disease in children and adults

The deamidated gliadin peptide (DGP) IgG antibody test is a crucial tool in the diagnostic landscape of celiac disease, an autoimmune disorder triggered by gluten ingestion. While elevated levels of these antibodies are often indicative of the condition, understanding what a low or decreased deamidated gliadin IgG antibody result signifies is equally important. This article delves into the nuances of low DGP IgG levels, exploring their implications, diagnostic value, and how they fit into the broader picture of celiac disease screening.

What are Deamidated Gliadin Peptide (DGP) Antibodies?

When individuals with celiac disease consume gliadin, a protein found in wheat, barley, and rye, their immune system mistakenly attacks the small intestine. In response to this, the body produces antibodies, including those against deamidated gliadin peptides (DGP). These peptides are formed when gliadin is modified during digestion. The presence of specific IgG antibodies against DGP, along with IgA antibodies, can signal the presence of celiac disease. These antibodies are particularly significant as they are recognized by the immune system as foreign invaders.

The Role of DGP IgG in Celiac Disease Diagnosis

The deamidated gliadin peptide (DGP) IgG test, often performed alongside other serological markers like tissue transglutaminase (tTG) antibodies, plays a vital role in diagnosing celiac disease. It measures the level of IgG antibodies targeting deamidated gliadin peptides. This test is especially valuable in specific scenarios:

* Low IgA Levels or IgA Deficiency: For individuals with low IgA levels or a diagnosed IgA deficiency, standard IgA-based celiac disease tests may yield false-negative results. In such cases, DGP IgG testing becomes indispensable. The American College of Gastroenterology recommends performing DGP IgG testing along with anti-tTG IgG for individuals with low IgA or IgA deficiency. This ensures a more comprehensive evaluation, as DGP IgG can detect celiac disease in individuals with IgA deficiency because it can test for two types of antibodies (IgA and IgG) in only one test.

* Children Under Two Years of Age: DGP IgA and IgG tests are recommended to be combined with anti-tTG IgA and IgG tests when screening children under two years of age for celiac disease. This is because younger children may not yet produce sufficient IgA antibodies.

* Complementary Testing: Even in individuals with normal IgA levels, a positive DGP IgG result can contribute to the diagnostic picture, especially when other tests are borderline or inconclusive. The deamidated gliadin peptide (DGP) IgG test is an important part of a comprehensive panel, including the Celiac Disease Comprehensive Panel, which is used to help diagnose celiac disease in children and adults.

Interpreting Low Deamidated Gliadin Peptide IgG Levels

A low or negative deamidated gliadin peptide IgG antibody result generally indicates a decreased likelihood of celiac disease, provided the individual has been consuming gluten regularly. If the result is negative for deamidated gliadin IgG antibodies, it likely means you don't have the condition, especially if you are at low risk.

However, it's crucial to understand that a low level doesn't always definitively rule out the condition. Several factors can influence test results:

* Gluten-Free Diet: If an individual has already adopted a gluten-free diet, DGP levels may decline and even disappear without a gluten-free diet. This observation questions DGP's specificity for diagnosing celiac disease in individuals who are no longer consuming gluten. Therefore, serological testing for celiac disease is most accurate when performed while the patient is still consuming gluten.

* Early Stages of the Disease: In the very early stages of celiac disease, antibody levels might not yet be significantly elevated.

* Other Autoimmune Conditions: While DGP IgG is strongly associated with celiac disease, isolated positive DGP IgG results in the absence of other markers can have a low diagnostic yield for celiac disease in children and may be indicative of other conditions.

* Individual Variability: Antibody production can vary from person to person. A low level might simply reflect a weaker immune response in a particular individual.

Deamidated Gliadin Peptide (DGP) IgG vs. Other Celiac Markers

While DGP IgG is a valuable marker, it's often interpreted in conjunction with other tests:

* Tissue Transglutaminase (tTG) Antibody: The tissue transglutaminase antibody, IgG, serum test is another primary screening tool for celiac disease. A positive tTG and/or DGP IgG antibody results indicate celiac disease, however, a small intestinal biopsy is still required to establish a definitive diagnosis.

* Gliadin Antibodies: Older tests for **gliadin antibodies